{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/abbvie-inc/","json":"https://alysly.com/json/markets/stocks/abbvie-inc/index.json","lang":"en-US","title":"AbbVie Inc. (ABBV) Stock Price Today | US00287Y1091 | News","description":"AbbVie Inc. (ABBV). Held in 22 ETFs (top 7.66% in XUHL). Revenue $61.2bn, net margin 6.9% (FY ended Dec 2025). ISIN US00287Y1091 · WKN A1J84E.","modified":"2026-11-01T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/abbvie-inc/","json":"https://alysly.com/json/de/maerkte/aktien/abbvie-inc/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"AbbVie Inc.","url":"https://alysly.com/markets/stocks/abbvie-inc/"}],"content":[{"type":"heading","level":1,"text":"AbbVie Inc. (ABBV)"},{"type":"paragraph","text":"ABBV · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"AbbVie Inc. (ABBV) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 7.66%. Anyone who holds an ETF containing AbbVie also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: AbbVie"},{"type":"heading","level":3,"text":"Key Data for AbbVie"},{"type":"facts","items":[{"label":"Held in","value":"22 ETFs"},{"label":"Highest weight","value":"7.66%"},{"label":"Indices","value":"11"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US00287Y1091"},{"label":"WKN","value":"A1J84E"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"AbbVie Stock Price Chart"},{"type":"paragraph","text":"The AbbVie chart shows daily closing prices and is set to the current year by default. The stock is up 29.1% year to date and up 29.2% over twelve months. The last recorded close on October 30, 2026, was $294.89, at 100% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Jul 11, 2024, 580 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"AbbVie Stock Performance"},{"type":"table","caption":"AbbVie stock performance","rows":[["Year to date","+29.1%","1 year","+29.2%"],["1 month","+12.7%","3 months","+17.5%"],["Calendar year 2025","+28.6%","",""]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, AbbVie is up 35.7% year to date and up 33.6% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: AbbVie"},{"type":"heading","level":3,"text":"What ETF Is AbbVie In?"},{"type":"paragraph","text":"AbbVie has above-average ETF coverage and is held by 22 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 85.1% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is AbbVie in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XUHL / XUHC","links":[{"text":"XUHL","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-health-care-ucits-etf-1c/"}]},{"text":"MSCI USA Health Care","href":"https://alysly.com/markets/indices/msci-usa-health-care/"},"7.66%","€76.59"],[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"5.67%","€56.73"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"5.67%","€56.67"],[{"text":"SPYD","href":"https://alysly.com/markets/etfs/spdr-sp-us-dividend-aristocrats-ucits-etf-dist/"},{"text":"S&P High Yield Dividend Aristocrats","href":"https://alysly.com/markets/indices/sp-us-dividend-aristocrats/"},"1.32%","€13.24"],[{"text":"SPYL / SPY5","links":[{"text":"SPYL","href":"https://alysly.com/markets/etfs/state-street-spdr-sp-500-ucits-etf-acc/"}]},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.77%","€7.74"],[{"text":"XD9U / XD9D","links":[{"text":"XD9U","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-ucits-etf-1c/"}]},{"text":"MSCI USA","href":"https://alysly.com/markets/indices/msci-usa/"},"0.77%","€7.72"],[{"text":"SXR8","href":"https://alysly.com/markets/etfs/ishares-core-sp-500-ucits-etf-acc/"},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.77%","€7.70"],[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"},{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"},"0.65%","€6.49"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.56%","€5.64"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.56%","€5.64"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.56%","€5.64"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.56%","€5.60"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.50%","€5.04"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.50%","€5.02"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.50%","€5.00"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.46%","€4.65"],[{"text":"XDEW","href":"https://alysly.com/markets/etfs/xtrackers-sp-500-equal-weight-ucits-etf-1c/"},{"text":"S&P 500 Equal Weight","href":"https://alysly.com/markets/indices/sp500-equal-weight/"},"0.23%","€2.25"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to AbbVie, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding AbbVie (weight per latest SEC filing): VYM 1.80%, IVV 0.69%, SPY 0.69%, VOO 0.69%, VTI 0.61%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"VYM","href":"https://alysly.com/markets/etfs/us/vym/"},{"text":"IVV","href":"https://alysly.com/markets/etfs/us/ivv/"},{"text":"SPY","href":"https://alysly.com/markets/etfs/us/spy/"},{"text":"VOO","href":"https://alysly.com/markets/etfs/us/voo/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"AbbVie among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 22 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"AbbVie Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"AbbVie: weight in EUNL 0.27% → 0.56%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 29, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), AbbVie had a weight of 0.27% on Sep 30, 2019 and 0.56% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.56% on Dec 30, 2022. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much AbbVie overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Which Tracked Investors Hold AbbVie?"},{"type":"paragraph","text":"AbbVie is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds AbbVie reduced its position.","links":[{"text":"GOOGL","href":"https://alysly.com/markets/stocks/alphabet-inc-class-a/"}]},{"type":"table","caption":"Tracked investors holding this stock","columns":["Investor","Shares","Value","Quarter"],"rows":[["Bridgewater Associates","11,775","$3M","reduced by 18,587"]]},{"type":"paragraph","text":"As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to AbbVie"},{"type":"table","caption":"Stocks with ETF exposure similar to AbbVie","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["AbbVie","–","–","+29.2%","26.5%","6.9%","+8.6%"],[{"text":"Abbott Laboratories","href":"https://alysly.com/markets/stocks/abbott-laboratories/"},"22","–","-14.8%","24.0%","14.7%","+5.7%"],[{"text":"Cardinal Health","href":"https://alysly.com/markets/stocks/cardinal-health-inc/"},"22","–","+31.9%","26.3%","0.7%","+14.2%"],[{"text":"Cencora","href":"https://alysly.com/markets/stocks/cencora-inc/"},"22","–","-3.0%","26.1%","0.5%","+9.3%"],[{"text":"McKesson Corporation","href":"https://alysly.com/markets/stocks/mckesson-corporation/"},"21","–","+20.5%","28.4%","1.2%","+12.4%"],[{"text":"STERIS","href":"https://alysly.com/markets/stocks/steris-plc/"},"21","–","-3.8%","23.8%","13.2%","+8.7%"],[{"text":"Edwards Lifesciences Corporation","href":"https://alysly.com/markets/stocks/edwards-lifesciences-corporation/"},"21","–","+10.2%","25.0%","17.7%","+11.5%"],[{"text":"HCA Healthcare Inc","href":"https://alysly.com/markets/stocks/hca-healthcare-inc/"},"21","–","+1.4%","29.0%","9.0%","+7.1%"],[{"text":"Eli Lilly and Company","href":"https://alysly.com/markets/stocks/eli-lilly-and-company/"},"21","+0.65","+67.9%","38.0%","31.7%","+44.7%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as AbbVie. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: AbbVie"},{"type":"heading","level":3,"text":"AbbVie Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$61.2B"},{"label":"Net income","value":"$4.2B"},{"label":"Diluted EPS","value":"$2.36"},{"label":"Net margin","value":"6.9%"},{"label":"Return on equity","value":"-129.2%"},{"label":"Equity ratio","value":"-2.4%"},{"label":"Revenue growth","value":"+8.6%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","54.3","4.9","9.0%"],["FY ended Dec 2024","56.3","4.3","7.6%"],["FY ended Dec 2025","61.2","4.2","6.9%"]]},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":3,"id":"patents","text":"Latest Patents Granted to AbbVie"},{"type":"paragraph","text":"In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, AbbVie received 6 utility patents and 2 design patents. That is 0.002% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 3.0 years."},{"type":"table","caption":"The five most recent utility patents granted to AbbVie","columns":["Granted","Patent","Title","Filed","Technology field"],"rows":[["Aug 25, 2026","US 12715917 B2","Methods of using anti-hemojuvelin (HJV) antibodies for treating myelofibrosis","Nov 24, 2025","C07K Chemistry; metallurgy"],["Aug 25, 2026","US 12715916 B2","Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis","Nov 3, 2025","C07K Chemistry; metallurgy"],["Jun 16, 2026","US 12655210 B2","Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease","May 13, 2021","C07K Chemistry; metallurgy"],["May 12, 2026","US 12623820 B2","Container cap and method of piercing a seal covering an opening of a container","Apr 16, 2018","B65D Containers and packaging"],["Mar 10, 2026","US 12570664","Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof","–","C07D Chemistry; metallurgy"]]},{"type":"paragraph","text":"These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. Titles as published by the office; median time based on 4 patents with a known filing date."},{"type":"paragraph","text":"The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.","links":[{"text":"patent screener","href":"https://alysly.com/tools/patent-screener/#c=abbvie-inc"},{"text":"M&A and patents","href":"https://alysly.com/m-and-a/"}]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: AbbVie"},{"type":"heading","level":3,"text":"AbbVie Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-21.5%"},{"label":"Annualized volatility","value":"26.5%"}]},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"facts","items":[{"label":"Below peak","value":"0.0%"},{"label":"Beta to S&P 500","value":"-0.17"},{"label":"Correlation to S&P 500","value":"-0.08"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was the highest since our series began on Jul 11, 2024. When the S&P 500 rose or fell 1%, AbbVie moved 0.17% on average in the opposite direction (past 252 trading days). The correlation of -0.08, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of AbbVie."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":3,"text":"What AbbVie Correlates With"},{"type":"table","caption":"What AbbVie Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Eli Lilly and Company","href":"https://alysly.com/markets/stocks/eli-lilly-and-company/"},"+0.65",""],[{"text":"Johnson & Johnson","href":"https://alysly.com/markets/stocks/johnson-johnson/"},"+0.65",""],[{"text":"Royalty Pharma Plc Class A","href":"https://alysly.com/markets/stocks/royalty-pharma-plc-class-a/"},"+0.65",""],[{"text":"Biogen Inc.","href":"https://alysly.com/markets/stocks/biogen-inc/"},"+0.61",""],[{"text":"Astrazeneca plc","href":"https://alysly.com/markets/stocks/astrazeneca-plc/"},"+0.60",""],[{"text":"Vertex Pharmaceuticals Incorporated","href":"https://alysly.com/markets/stocks/vertex-pharmaceuticals-incorporated/"},"+0.60",""],[{"text":"Bloom Energy Corporation Class A","href":"https://alysly.com/markets/stocks/bloom-energy-corporation-class-a/"},"-0.52",""],[{"text":"Eaton Corp. Plc","href":"https://alysly.com/markets/stocks/eaton-corp-plc/"},"-0.51",""],[{"text":"Lumentum Holdings Inc.","href":"https://alysly.com/markets/stocks/lumentum-holdings-inc/"},"-0.51",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 14","href":"#dn-14"},{"type":"heading","level":2,"id":"refs","text":"Related Content: AbbVie"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 1, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-8","text":"Holdings as of quarter end from the mandatory filings (Form 13F) with the US securities regulator; the deadline runs up to 45 days."},{"id":"dn-9","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-10","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-11","text":"Grants by the US patent office from its weekly publications (public domain, source: USPTO), counted by the owner at the time of grant."},{"id":"dn-12","text":"Computed from the full available price history."},{"id":"dn-13","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-14","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/abbvie-inc/#webpage","url":"https://alysly.com/markets/stocks/abbvie-inc/","name":"AbbVie Inc. – Alysly","description":"AbbVie Inc. (ABBV). Held in 22 ETFs (top 7.66% in XUHL). Revenue $61.2bn, net margin 6.9% (FY ended Dec 2025). ISIN US00287Y1091 · WKN A1J84E.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-01T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/abbvie-inc/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"AbbVie Inc."}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/abbvie-inc/#entity","name":"AbbVie Inc.","tickerSymbol":"ABBV","url":"https://alysly.com/markets/stocks/abbvie-inc/","mainEntityOfPage":"https://alysly.com/markets/stocks/abbvie-inc/","description":"AbbVie Inc. (ABBV). Held in 22 ETFs (top 7.66% in XUHL). Revenue $61.2bn, net margin 6.9% (FY ended Dec 2025). ISIN US00287Y1091 · WKN A1J84E.","logo":"https://alysly.com/stock-logos/abbvie-logo.webp","image":"https://alysly.com/stock-logos/abbvie-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"ABBV"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US00287Y1091"},{"@type":"PropertyValue","propertyID":"WKN","value":"A1J84E"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"AbbVie Inc. — key figures","url":"https://alysly.com/markets/stocks/abbvie-inc/","description":"AbbVie Inc. (ABBV). Held in 22 ETFs (top 7.66% in XUHL). Revenue $61.2bn, net margin 6.9% (FY ended Dec 2025). ISIN US00287Y1091 · WKN A1J84E.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":22},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":7.6594},{"@type":"PropertyValue","name":"YTD return (%)","value":29.1},{"@type":"PropertyValue","name":"1-year return (%)","value":29.2},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":61160000000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":4226000000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":133960000000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":-3270000000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":2.36},{"@type":"PropertyValue","name":"Net margin (%)","value":6.9},{"@type":"PropertyValue","name":"Return on equity (%)","value":-129.20000000000002},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2024-07-11/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}